SB-204990
Fa'amatalaga Oloa
Faailoga o oloa
Tele o le afifi | Avanoa | Tau (USD) |
Igoa vaila'au:
trans-5-[6-(2,4-Dichlorophenyl)hexyl]tetrahydro-3-hydroxy-2-oxo-3-furanacetic acid
SMILES Code:
O=C(O)C[C@@]1(O)C(O[C@H](CCCCCCC2=CC=C(Cl)C=C2Cl)C1)=O
InChi Code:
InChI=1S/C18H22Cl2O5/c19-13-8-7-12(15(20)9-13)5-3-1-2-4-6-14-10-18(24,1) 1-16(21)22)17(23)25-14/h7-9,14,24H,1-6,10-11H2,(H,21,22)/t14-,18-/m1/s1
InChi Key:
YTRNLFYTHYWDAU-RDTXWAMCSA-N
upu autu:
SB-204990, SB 204990, SB204990
Solubility:
Teuina:
Fa'amatalaga:
SB-204990 o le prodrug o le malosi ATP citrate-lyase inhibitor SB-201076. SB-204990, pe a tuʻuina atu tautala i isumu, na faʻafefe i totonu o le faʻaogaina o le tino, o vailaʻau talafeagai o le SB-201076 na toe maua i le ate. SB-204990 (25 mg/kg i le aso) na faʻaititia ai foi le maualuga o le cholesterol plasma (e oʻo atu i le 23%) ma le maualuga o le triglyceride (e oʻo atu i le 38%) i le taifau, e sili atu le faʻaitiitia o le lipoprotein maualalo pe a faʻatusatusa i le maualuga-density lipoprotein cholesterol. tulaga. O le SB-204990 ose enzyme taua i le puleaina o le sapalai o mea'ai mo le lipid synthesis de novo ma se fa'amoemoega ole enzyme mo le hypolipidaemic intervention.
Sini: